scholarly journals A Cathepsin B-like Protease Is Required for Host Protein Degradation inTrypanosoma brucei

2004 ◽  
Vol 279 (46) ◽  
pp. 48426-48433 ◽  
Author(s):  
Zachary B. Mackey ◽  
Theresa C. O'Brien ◽  
Doron C. Greenbaum ◽  
Rebecca B. Blank ◽  
James H. McKerrow
2008 ◽  
Vol 283 (43) ◽  
pp. 28934-28943 ◽  
Author(s):  
Theresa C. O'Brien ◽  
Zachary B. Mackey ◽  
Richard D. Fetter ◽  
Youngchool Choe ◽  
Anthony J. O'Donoghue ◽  
...  

1988 ◽  
Vol 45 (1) ◽  
pp. 140-144 ◽  
Author(s):  
Robert P. Hummel ◽  
Brad W. Warner ◽  
J.Howard James ◽  
Per-Olof Hasselgren ◽  
Josef E. Fischer

1977 ◽  
Vol 164 (2) ◽  
pp. 399-407 ◽  
Author(s):  
Melvyn F. Hopgood ◽  
Michael G. Clark ◽  
F. John Ballard

1. Isolated parenchymal cells were prepared by collagenase perfusion of livers from fed rats that had been previously injected with [3H]leucine to label liver proteins. When these cells were incubated in a salts medium containing glucose, gelatin and EDTA, cellular integrity was maintained over a period of 6h. 2. Cells incubated in the presence of 2mm-leucine to minimize radioactive isotope reincorporation released [3H]leucine into the medium at a rate accounting for the degradation of 4.5% of the labelled cell protein per h. 3. Degradation of [3H]protein in these cells was inhibited by insulin and by certain amino acids, of which tryptophan and phenylalanine were the most effective. 4. Protein degradation was decreased by several proteinase inhibitors, particularly those that are known to inhibit lysosomal cathepsin B, and by inhibitors of cell-energy production. 5. Ammonia inhibited degradation, but only at concentrations above 1.8mm. Aliphatic analogues of ammonia were effective at lower concentrations than was ammonia. 6. High concentrations of ammonia inhibited degradation by 50%. The extent of this inhibition could not be increased further by the addition of the cathepsin B inhibitor leupeptin, which by itself inhibited degradation by approx. 30%. 7. The sensitivity of proteolysis in isolated hepatocytes to these various inhibitory agents is discussed in relation to their possible modes of action.


2015 ◽  
Vol 83 (8) ◽  
pp. 3164-3175 ◽  
Author(s):  
Krithika Rajaram ◽  
David E. Nelson

The ability of certain species ofChlamydiato inhibit the biogenesis of phagolysosomes permits their survival and replication within macrophages. The survival of macrophage-adapted chlamydiae correlates with the multiplicity of infection (MOI), and optimal chlamydial growth occurs in macrophages infected at an MOI of ≤1. In this study, we examined the replicative capacity ofChlamydia muridarumin the RAW 264.7 murine macrophage cell line at different MOIs.C. muridarumproductively infected these macrophages at low MOIs but yielded few viable elementary bodies (EBs) when macrophages were infected at a moderate (10) or high (100) MOI. While high MOIs caused cytotoxicity and irreversible host cell death, macrophages infected at a moderate MOI did not show signs of cytotoxicity until late in the infectious cycle. Inhibition of host protein synthesis rescuedC. muridarumin macrophages infected at a moderate MOI, implying that chlamydial growth was blocked by activated defense mechanisms. Conditioned medium from these macrophages was antichlamydial and contained elevated levels of interleukin 1β (IL-1β), IL-6, IL-10, and beta interferon (IFN-β). Macrophage activation depended on Toll-like receptor 2 (TLR2) signaling, and cytokine production required live, transcriptionally active chlamydiae. A hydroxyl radical scavenger and inhibitors of inducible nitric oxide synthase (iNOS) and cathepsin B also reversed chlamydial killing. High levels of reactive oxygen species (ROS) led to an increase in cathepsin B activity, and pharmacological inhibition of ROS and cathepsin B reduced iNOS expression. Our data demonstrate that MOI-dependent TLR2 activation of macrophages results in iNOS induction via a novel ROS- and cathepsin-dependent mechanism to facilitateC. muridarumclearance.


2020 ◽  
Author(s):  
Celestina Mazzotta ◽  
Grace Marden ◽  
Alessandra Farina ◽  
Andreea Bujor ◽  
Marcin A. Trojanowski ◽  
...  

Author(s):  
Kai-Min Lin ◽  
Katie Nightingale ◽  
Lior Soday ◽  
Robin Antrobus ◽  
Michael P. Weekes

Human cytomegalovirus (HCMV) is an important pathogen in immunocompromised individuals and neonates, and a paradigm for viral immune evasion. We previously developed a quantitative proteomic approach that identified 133 proteins degraded during the early phase of HCMV infection, including known and novel antiviral factors. The majority were rescued from degradation by MG132, which is known to inhibit lysosomal cathepsins in addition to the proteasome. Global definition of the precise mechanisms of host protein degradation is important both to improve our understanding of viral biology, and to inform novel antiviral therapeutic strategies. We therefore developed and optimized a multiplexed comparative proteomic analysis using the selective proteasome inhibitor bortezomib in addition to MG132, to provide a global mechanistic view of protein degradation. Of proteins rescued from degradation by MG132, 34–47 proteins were also rescued by bortezomib, suggesting both that the predominant mechanism of protein degradation employed by HCMV is via the proteasome, and that alternative pathways for degradation are nevertheless important. Our approach and data will enable improved mechanistic understanding of HCMV and other viruses, and provide a shortlist of candidate restriction factors for further analysis.


Cell Reports ◽  
2020 ◽  
Vol 30 (7) ◽  
pp. 2248-2260.e5 ◽  
Author(s):  
Vu Thuy Khanh Le-Trilling ◽  
Tanja Becker ◽  
Aharon Nachshon ◽  
Noam Stern-Ginossar ◽  
Lara Schöler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document